Materials and Methods

Rosetta design
The homotrimer of TMD5 was homology modeled according to a reasonable NMR coiled-coil structure (PDB ID 1AQ5) and validated via experiments previously 1, 2 . The anti-TMD5 peptide was designed using the Rosetta molecular modelling package 3 . The previously built model of TMD5 trimeric complex was used as the template and chain A was defined as the origin for the design of anti-TMD5 2 . The hydrogen-bonding network between the aspartic acid residues at position 150 was determined to be a driving force for the trimerization of the TMD5 peptides, thus the aspartic acid was retained in the anti-TM5 peptide design. The identities for all remaining anti-TMD5 sequence positions located at the trimeric interface were allowed to vary, while alternate side-chain conformations were sampled for the wild-type TMD5 peptides in order to search for a lower energy structure. A version of the Rosetta energy function with a dampened Lennard-Jones repulsion potential was used 4 . 50 designs were generated, and an anti-TMD5 sequence with the lowest score was selected for characterization based on the RosettaDesign energy function [5] [6] [7] [8] .
Molecular dynamics simulations
The homotrimeric TMD5 and the heterotrimer (one anti-TMD5 helix with lowest score in Rosetta and two wild type TMD5 helixes) were embedded in a1,2-dimyristoyl-sn-glycero-3-phosphocholine(DMPC) bilayer and solvated in a 62×62×78 Å 3 box filled with TIP3P water molecules via the CHARMM-GUI membrane builder protocol 9 . 150 mM KCl was added to neutralize the system and mimic the physiological concentration. The protein, lipids, and ions were described by the CHARMM36 force field 10, 11 and all MD simulations were performed by the NAMD2.12 program package 12 . The models with ~30,000 atoms were simulated under the NPT ensemble with a pressure of 1 atm at 310.15 K. The Nosé-Hoover Langevin piston method 13, 14 was applied for the pressure control and the Langevin thermostat for the temperature coupling. Long-range electrostatic interactions were treated by the particle mesh Ewald (PME) algorithm 15 . Non-bonded interactions were switched off at 10 ~ 12 Å. Periodic boundary conditions were applied in all directions and the time step was set as 2 fs. After a staged equilibration with a gradual decrease in harmonic constraints that act on heavy lipid and protein atoms only, further non-constrained relaxations were run for 100 ns for analysis.
Peptide synthesis
TMD5, Coumarin-tagged TMD5, anti-TMD5, FITC-tagged anti-TMD5, anti-TMD5 scramble, and FITC-tagged anti-TMD5 scramble were prepared by standard microwave-assisted solid-phase synthesis. The purity and identity of these peptide were confirmed by HPLC (>95%) and mass spectrometry (see Appendix Data). The concentrations of anti-TMD5/anti-TMD5 scramble and TMD5 were determined by absorbance at 280 nm using the extinction coefficient of 34490 M -1 cm -1 and 6990 M -1 cm -1 , respectively. The concentration of coumarin labeled TMD5 peptide was determined by absorbance at 400 nm using an extinction coefficient of 39300 M -1 cm -1 . The concentration of FITC-tagged anti-TMD5/FITC-tagged anti-TMD5 scramble was determined by absorbance at 495 nm using an extinction coefficient of 84000 M -1 cm -1 . Peptide Sequence: TMD5
KKKK-WQLLAFFLAFFLDLILLIIALYL-KKKK Coumarin-tagged TMD5 coumarin-GKKKK-WQLLAFFLAFFLDLILLIIALYL-KKKK anti-TMD5 KKKK-WWKLWYFLVWFLDLIILILLLWW-KKKK FITC-tagged anti-TMD5 FITC-GKKKK-WWKLWYFLVWFLDLIILILLLWW-KKKK anti-TMD5 scramble KKKK-VFLWLWLIWIFIDWKLWLLYWLL-KKKK FITC-tagged anti-TMD5 scramble FITC-GKKKK-VFLWLWLIWIFIDWKLWLLYWLL-KKKK Fluorescence dequenching assay 100 μL of coumarin-tagged TMD5 peptide (50 nM) solution (50 mM HEPES, 150 μM C14 betaine, pH = 7.4) with the indicated concentration of unmodified anti-TMD5/anti-TMD5 scramble or NSC 259242 was pipetted into black 96-well plates in triplicate. Samples were mixed and allowed to sit at room temperature in the dark overnight to reach equilibrium and then excited at 360 nm and emission was read at 430 nm using a SYNERGY H1 Micro-plate Reader (BioTek Instruments, Carlsbad, CA, USA). The relative fluorescence intensity was normalized by TMD-5 fluorescence in the absence of TMD-5 inhibitor.
FRET assay
Fluorescence resonance energy transfer (FRET) experiments were conducted under room temperature in a 2×10 mm quartz cell (Starna Cells, Atascadero, CA, USA) on a Cary Eclipse spectrofluorimeter (Agilent Technologies, Santa Clara, CA, USA). 50 nM (7-hydroxy-3-carboxyamide coumarin)-labeled TMD5 peptide in 20 mM HEPES, pH = 7.4 and 1.0 mM C14 betaine micelles (or 1.0 mM bicelles composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and dihexanoylphosphatidylcholine (DHPC), q = 0.3) buffer was titrated with increasing concentrations of FITC-tagged anti-TMD5 or FITC-tagged anti-TMD5 scramble. 415 nm was chosen as the excitation. Emission at 400-600 nm was recorded. Samples containing the same amount of fluorescence acceptor (FITC-tagged anti-TMD5/ FITC-tagged anti-TMD5 scramble) served as a reference. The net FRET signals (total signal -reference signal) were used. The quenching of fluorescence signal of coumarin-labeled TMD5 peptide was analyzed by the equation, log (F 0 /F-1) = -logK d + n×log ([FITC-tagged anti-TMD5]).
Dominant-negative ToxR assay
Plasmids for this assay, pTox7 and pTox6, and the competent E. coli strain, FHK12, were kindly provided by Dr. Langosh, Technische Universität München, Germany. The pTox7 plasmid was modified by insertion of a single base (T) after the BamH1 site to keep the proper reading frame for the designed transmembrane sequences 16, 17 . TMD5-ToxR (pTox7-TMD5), anti-TMD5-ToxR* (pTox6-TMD5), anti-TMD5 scramble-ToxR* (pTox6-TMD5 scramble) and poly Leu-ToxR* (pTox6-poly Leu) constructs were made as described previously 16, 17 . ToxR construct (200 ng) and ToxR* construct (200 ng) were transformed into E. coli strain FHK12 by heat shock method. 50 µL of each transformation was used to inoculate, in triplicate, 5 mL of Luria-Bertani broth containing chloramphenicol (35 µg/mL), kanamycin (33 μg/mL) and 0.0025% arabinose. Cultures were incubated with shaking at 37 °C for 20 h and βgalactosidase activity was measured using a Beckman Coulter DTX 880 plate reader (Beckman Coulter, CA, USA). Briefly, 5 μL of culture was transferred to the wells of a Costar 3596 polystyrene 96-well plate (Corning, NY, USA) containing 100 μL Z buffer/chloroform (1% β-mercaptoethanol, 10% chloroform, 89% A buffer: 1 M sodium phosphate, 10 mM KCl, 1 mM MgSO4 and pH 7.0). Cells were lysed by addition of 50 μL Z buffer/ SDS (1.6% w/v sodium dodecyl sulfate in Z buffer) and shaking at 28 °C for 10 min. 50 μL Z buffer/ o-nitro phenyl galactoside (ONPG, 0.4% w/v in Z buffer) was added and βgalactosidase activity was measured by monitoring the reaction at 405 nm for a period of 20 min at 28°C. Miller units were calculated using the following equation: Miller units = (OD 405 nm /min)/OD 600 nm ×1000.
NF-κB assay
B lymphoblastoid 721 cell line NF-κB reporter cell was constructed previously 18 , where the firefly luciferase gene was placed under the control of the NF-κB transcriptional response element. B721 NF-κB reporter cells were cultured in RPMI medium supplemented with 10% fetal bovine serum (FBS), penicillin (50 unit/mL) and streptomycin (50 µg/mL). Cells were seeded at a density of 1×10 4 cells/well in 96-well plates (100 µL/well). After overnight incubation, different concentrations of peptide were added to the cells. Following 24 h of treatment, the NF-κB activity was detected by Steady-Glo Luciferase Assay System (Promega, Madison, MI, USA) according to manufacturer's instructions. Briefly, 75 µL Steady-Glo Luciferase Assay reagent was added to each well and incubated at room temperature for 15 min. The luminescence was subsequently measured. S6 . Locations of four water molecules in heterotrimer_2:1 (two anti-TMD5s and one TMD5). The distance between the oxygen of each water molecule and the center of mass of the Cα of heterotrimer_2:1 were calculated and represented by black, red, blue, and magenta lines, respectively. The location of four water molecules in heterotrimer_2:1 was displayed and numbered with 1, 2, 3, and 4. W139 and D150 were represented in cyan sticks. Fig. S7 . Cell viability assay. B721 cells were stimulated for indicated concentrations of anti-TMD5 and anti-TMD5 scramble. Higher concentrations (> 4 µM) were not tested because of their poor solubility. TMD5/anti-TMD5 stock solutions were prepared as following: They were dissolved in 2,2,2-trifluoroethanol. The organic solvent was removed under reduced pressure to generate a thin film of peptide, which was then dissolved in 20 mM HEPES buffer (pH=7.4) containing micelle (C14 betaine) or bicelles (POPC/DHPC or DMPC/DHPC). Following 24 h treatment, 20 µL of Cell Proliferation Reagent WST-1 (Roche Diagnostics GmbH, Mannheim, Germany) was added. After further incubation at 37 °C for 1-2 h, the absorbance at 450 nm was measured on a SYNERGY H1 Micro-plate Reader (BioTek Instruments, Carlsbad, CA, USA) and 620 nm was chosen as the reference wavelength. The A 450 nm -A 620 nm for the control group was set as 100%. 
Appendix data: HPLC and mass spectrometry characterizations of the synthesized peptides
